COVID-19 Remote Monitoring

Vivek Reddy

Status: Withdrawn

Conditions: COVID-19; Cardiac Arrhythmias

Treatments: Diagnostic Test: VitalConnect Vital Sign Patch

Study type: Interventional

Funder types: Other

Identifiers

NCT04350476

GCO 20-0932

Details and patient eligibility

About

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.

Full description

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either

  1. Not admitted to the hospital, and permitted to recover at home
  2. Discharged from inpatient hospitalization, during the acute recovery period

• 18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).

Exclusion criteria

N/A

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Vital Connect Patch Arm

Other group

Description:

This is a non-randomized study. Based on clinical assessment, patients will be provided with the following home monitoring system: VitalConnect Vital Sign Patch (FDA approved for this indication)

Treatment:

Diagnostic Test: VitalConnect Vital Sign Patch